Interviews
Over the past few months, we have welcomed four new members to the ECMC team. Lamise Nasr, Paediatric Network Manager; Molly Obadiah, Digital Healthcare Business Development Manager; Meghan Quirke, Website Executive Intern and Mollie Stebbings, Data Analyst (Clinical Trials). Find out more about them here.
We recently welcomed Khat Ali as the new Project Officer in the ECMC team. Khat has replaced Caroline Huxley as Project Officer but luckily for us Caroline has remained in the ECMC Programme Office. Caroline is now the Cancer Research UK Paediatric Manager and will be working to deliver the CRUK for Children and Young People's research strategy to drive progress for children and young people's cancer research.
Which ECMC are you based at?
I'm based at Bristol Children's Hospital (Paediatric & Teenage and Young Adult Cancer Units)
Can you tell us a little about your career so far?
I was a Paediatric Oncology research fellow with the Institute of Cancer Studies in University of Manchester and a national grid trainee in Paediatric Oncology in Birmingham Children's Hospital, prior to taking up my current consultant post.
What is your research area of focus?
With the ease of lockdown and the reopening of research labs, we spoke to scientists and quality assurance (QA) managers to understand more about their roles, and asked them to share what they are looking forward to and their thoughts on upcoming challenges.
We speak to Sarah Danson of Sheffield ECMC about her background and her vision for the Adult Network Strategy Group in 2020 and beyond.
Aoife Regan gives an update from the summer, discussing about the Phase I: Where Science Becomes Medicine conference, changes in the Programme Office, and her thoughts for the future.
The new Lead of the Birmingham ECMC talks to us about his career to date, the biggest challenges facing clinical research, and the exciting, unpredictable future for immunotherapy.
Gareth Veal discusses his team’s new therapeutic drug monitoring service, aiming to assist in the treatment particularly “hard-to-treat” childhood cancer patients.
Aoife Regan has recently returned from maternity leave back to her position as Head of the ECMC Programme Office. Aoife reflects on what’s changed in the network while she’s been away, what she’s planning to focus on and the challenges to come.
The new Lead of the Manchester ECMC talks to us about her career to date, balancing NHS service and clinical research commitments, precision medicine ... and the Enigma code.